Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

472 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
False Negative Tests for SARS-CoV-2 Infection - Challenges and Implications.
Woloshin S, Patel N, Kesselheim AS. Woloshin S, et al. Among authors: kesselheim as. N Engl J Med. 2020 Aug 6;383(6):e38. doi: 10.1056/NEJMp2015897. Epub 2020 Jun 5. N Engl J Med. 2020. PMID: 32502334 No abstract available.
US Spending Associated With Transition From Daily to 3-Times-Weekly Glatiramer Acetate.
Rome BN, Tessema FA, Kesselheim AS. Rome BN, et al. Among authors: kesselheim as. JAMA Intern Med. 2020 Jul 20;180(9):1-8. doi: 10.1001/jamainternmed.2020.2771. Online ahead of print. JAMA Intern Med. 2020. PMID: 32702083
Regulatory Decision-making on COVID-19 Vaccines During a Public Health Emergency.
Avorn J, Kesselheim A. Avorn J, et al. JAMA. 2020 Oct 6;324(13):1284-1285. doi: 10.1001/jama.2020.17101. JAMA. 2020. PMID: 32870268 No abstract available.
Rates and Costs of Dispensing Naloxone to Patients at High Risk for Opioid Overdose in the United States, 2014-2018.
Barenie RE, Gagne JJ, Kesselheim AS, Pawar A, Tong A, Luo J, Bateman BT. Barenie RE, et al. Among authors: kesselheim as. Drug Saf. 2020 Jul;43(7):669-675. doi: 10.1007/s40264-020-00923-6. Drug Saf. 2020. PMID: 32180134
Insulin access and affordability in the USA: anticipating the first interchangeable insulin product.
Luo J, Kesselheim AS, Sarpatwari A. Luo J, et al. Among authors: kesselheim as. Lancet Diabetes Endocrinol. 2020 May;8(5):360-362. doi: 10.1016/S2213-8587(20)30105-4. Epub 2020 Mar 20. Lancet Diabetes Endocrinol. 2020. PMID: 32203681 No abstract available.
Trends in Medicare Part D Inhaler Spending, 2012-2018.
Feldman WB, Gagne JJ, Kesselheim AS. Feldman WB, et al. Among authors: kesselheim as. Ann Am Thorac Soc. 2020 Nov 18. doi: 10.1513/AnnalsATS.202008-1082RL. Online ahead of print. Ann Am Thorac Soc. 2020. PMID: 33207126 No abstract available.
The Future of Drug-Pricing Transparency.
Feldman WB, Rome BN, Avorn J, Kesselheim AS. Feldman WB, et al. Among authors: kesselheim as. N Engl J Med. 2021 Jan 13. doi: 10.1056/NEJMp2033734. Online ahead of print. N Engl J Med. 2021. PMID: 33440087 No abstract available.
Buprenorphine for opioid use disorder: The role of public funding in its development.
Barenie RE, Kesselheim AS. Barenie RE, et al. Among authors: kesselheim as. Drug Alcohol Depend. 2020 Dec 21;219:108491. doi: 10.1016/j.drugalcdep.2020.108491. Online ahead of print. Drug Alcohol Depend. 2020. PMID: 33421798
Generic Competition for Drugs Treating Rare Diseases.
Beall RF, Quinn AE, Kesselheim AS, Tessema FA, Sarpatwari A. Beall RF, et al. Among authors: kesselheim as. J Law Med Ethics. 2020 Dec;48(4):789-795. doi: 10.1177/1073110520979391. J Law Med Ethics. 2020. PMID: 33404340 No abstract available.
Repurposing existing drugs for new uses: a cohort study of the frequency of FDA-granted new indication exclusivities since 1997.
Sahragardjoonegani B, Beall RF, Kesselheim AS, Hollis A. Sahragardjoonegani B, et al. Among authors: kesselheim as. J Pharm Policy Pract. 2021 Jan 4;14(1):3. doi: 10.1186/s40545-020-00282-8. J Pharm Policy Pract. 2021. PMID: 33397471 Free PMC article.
472 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback